查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1467762

2024-2032 年亨廷顿舞蹈症治疗市场报告（按类型、药物类型、年龄、配销通路、最终用户和地区）

Huntington's Disease Treatment Market Report by Type, Drug Type, Age, Distribution Channel, End User, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 135 Pages | 商品交期: 2-3个工作天内

价格

2023年全球IMARC Group舞蹈症治疗市场规模达4.911亿美元。亨廷顿舞蹈症发病率的上升、对该疾病治疗的先进药物的需求不断增加以及创新治疗方法的最新发展是推动市场的一些关键因素。

亨廷顿舞蹈症是指一种致命的神经退化性疾病，会导致大脑中的神经细胞进行性破坏。其症状包括各种运动、精神和认知障碍，如不自主抽搐、肌肉问题、组织和注意力困难、缺乏意识、失眠和社交退缩。亨廷顿氏症的治疗涉及多种药物的应用，例如抗精神病药、抗忧郁药、抗巴金森药和情绪稳定药。治疗过程还包括各种疗法，例如语言疗法、职业疗法、物理疗法和心理疗法。亨廷顿舞蹈症治疗有助于最大程度地减少运动和精神障碍的症状，帮助患者在更短的时间内适应新的能力，并制定应对策略。它还有助于改善日常任务、言语、保持姿势和平衡以及提高生活品质。

亨廷顿舞蹈症治疗市场趋势：

全球亨廷顿舞蹈症发生率的上升是推动市场成长的主要因素之一。亨廷顿舞蹈症治疗广泛用于抑制不自主的抽搐和扭动运动，治疗舞蹈症，减少暴力爆发和躁动，增强力量、灵活性、平衡性和协调性，从而改善生活品质并增强患者的能力执行日常任务，例如吃饭、通讯和行走。此外，对控制与亨廷顿舞蹈症相关的运动、认知和精神症状的先进药物的需求不断增加，也推动了市场的成长。与此一致的是，由于对该疾病及其根本原因的了解加深，新的疾病缓解药物的快速开发正在成为另一个生长诱导因素。此外，最近开发的创新治疗方法透过降低突变亨廷顿蛋白 (mTT) 的产生水平来阻止亨廷顿氏症的生长，对市场产生了积极影响。除此之外，使用反义寡核苷酸（ASO）靶向亨廷顿蛋白（HTT）信使核糖核酸（mRNA）及其整个中枢神经系统（CNS）蛋白质的反义技术的引入正在推动市场成长。此外，多个政府加大力度促进新药开发也有利于市场成长。其他因素，包括大众对亨廷顿病的认识不断提高、医疗保健行业的显着增长、研发（R&D）活动投资的增加、老年人口的增加以及对标籤外药物的需求不断增加，预计将推动市场的发展生长。

本报告回答的关键问题

  • 2023年全球亨廷顿舞蹈症治疗市场规模有多大？
  • 2024-2032年全球亨廷顿舞蹈症治疗市场的预期成长率是多少？
  • 推动全球亨丁顿舞蹈症治疗市场的关键因素是什么？
  • COVID-19 对全球亨廷顿舞蹈症治疗市场有何影响？
  • 全球亨廷顿舞蹈症治疗市场按类型划分是怎样的？
  • 根据药物类型，全球亨廷顿舞蹈症治疗市场的细分情况如何？
  • 全球亨廷顿舞蹈症治疗市场以年龄划分是怎样的？
  • 基于配销通路的全球亨廷顿舞蹈症治疗市场的细分情况如何？
  • 全球亨廷顿舞蹈症治疗市场的关键区域有哪些？
  • 全球亨廷顿舞蹈症治疗市场的主要参与者/公司有哪些？

目录

第一章：前言

第 2 章：范围与方法

  • 研究目的
  • 利害关係人
  • 资料来源
    • 主要资源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章：执行摘要

第 4 章：简介

  • 概述
  • 主要行业趋势

第 5 章：全球亨廷顿舞蹈症治疗市场

  • 市场概况
  • 市场业绩
  • COVID-19 的影响
  • 市场预测

第 6 章：市场区隔：按类型

  • 症状治疗
    • 市场走向
    • 市场预测
  • 疾病缓解疗法
    • 市场走向
    • 市场预测

第 7 章：市场区隔：依药物类型

  • 批准的药物
    • 市场走向
    • 关键环节
      • 丁苯那嗪
      • 丁苯那嗪
    • 市场预测
  • 标籤外药物
    • 市场走向
    • 市场预测

第 8 章：市场区隔：依年龄

  • 50岁以下
    • 市场走向
    • 市场预测
  • 50岁以上
    • 市场走向
    • 市场预测

第 9 章：市场区隔：按配销通路

  • 药局和零售药局
    • 市场走向
    • 市场预测
  • 医院药房
    • 市场走向
    • 市场预测
  • 网路药局
    • 市场走向
    • 市场预测

第 10 章：市场区隔：依最终用户

  • 医院
    • 市场走向
    • 市场预测
  • 居家护理
    • 市场走向
    • 市场预测
  • 专科诊所
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 11 章：市场区隔：按地区

  • 北美洲
    • 美国
      • 市场走向
      • 市场预测
    • 加拿大
      • 市场走向
      • 市场预测
  • 亚太
    • 中国
      • 市场走向
      • 市场预测
    • 日本
      • 市场走向
      • 市场预测
    • 印度
      • 市场走向
      • 市场预测
    • 韩国
      • 市场走向
      • 市场预测
    • 澳洲
      • 市场走向
      • 市场预测
    • 印尼
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 欧洲
    • 德国
      • 市场走向
      • 市场预测
    • 法国
      • 市场走向
      • 市场预测
    • 英国
      • 市场走向
      • 市场预测
    • 义大利
      • 市场走向
      • 市场预测
    • 西班牙
      • 市场走向
      • 市场预测
    • 俄罗斯
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 拉丁美洲
    • 巴西
      • 市场走向
      • 市场预测
    • 墨西哥
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 中东和非洲
    • 市场走向
    • 市场细分：按国家/地区
    • 市场预测

第 12 章：驱动因素、限制与机会

  • 概述
  • 司机
  • 限制
  • 机会

第 13 章：价值链分析

第 14 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 15 章：价格分析

第16章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • AOP Health
    • Apotex Inc.
    • Dr. Reddy's Laboratories Ltd.
    • H. Lundbeck A/S
    • Hikma Pharmaceuticals PLC
    • Lupin Limited
    • Prilenia Therapeutics
    • Sun Pharmaceutical Industries Limited
    • Teva Pharmaceutical Industries Ltd.
    • Vaccinex Inc.
Product Code: SR112024A6883

The global Huntington's disease treatment market size reached US$ 491.1 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 2,248.1 Million by 2032, exhibiting a growth rate (CAGR) of 17.9% during 2024-2032. The rising incidences of Huntington's disease, the increasing demand for advanced drugs for the disease treatment, and recent development of innovative therapeutic approaches represent some of the key factors driving the market.

Huntington's disease refers to a fatal neurodegenerative disorder that causes the progressive breakdown of nerve cells in the brain. Its symptoms include various movement, psychiatric, and cognitive impairments, such as involuntary jerking, muscle problems, difficulty in organizing and focusing, lack of awareness, insomnia, and social withdrawal. Huntington's disease treatment involves the application of various drugs, such as antipsychotics, antidepressants, antiparkinsonians, and mood-stabilizing drugs. The treatment process also includes various therapies, such as speech, occupational, physical, and psychotherapy. Huntington's disease treatment helps in minimizing the symptoms of movement and psychiatric disorders, assists patients in adapting to new abilities in a shorter time, and develops coping strategies. It also aids in improving everyday tasks, speech, maintaining posture and balance, and enhancing the quality of life.

Huntington's Disease Treatment Market Trends:

The rising incidence of Huntington's disease across the globe is one of the primary factors driving the market growth. Huntington's disease treatment is widely used to suppress involuntary jerking and writhing movement, treat chorea, reduce violent outbursts and agitation, and enhance strength, flexibility, balance, and coordination, which, in turn, improves the quality of life and enhances the patient's ability to carry out daily routine tasks, such as eating, communications, and walking. Furthermore, the increasing demand for advanced drugs to control the motor, cognitive, and psychiatric symptoms associated with Huntington's disease is providing an impetus to the market growth. In line with this, the rapid development of new disease-modifying drugs owing to the improved understanding of the disease, and its underlying causes are acting as another growth-inducing factor. Additionally, the recent development of the innovative therapeutic approach that deters the growth of Huntington's disease by reducing mutant huntingtin (mTT) production levels is positively influencing the market. Apart from this, the introduction of antisense technology that uses antisense oligonucleotides (ASOs) to target huntingtin (HTT) messenger ribonucleic acid (mRNA) and its protein throughout the central nervous system (CNS) is propelling the market growth. Moreover, increasing initiatives by several governments to promote the development of novel drugs are favoring the market growth. Other factors, including rising awareness among the masses regarding Huntington's disease, significant growth in the healthcare industry, increasing investment in research and development (R&D) activities, rising geriatric population, and escalating demand for off-label medications, are anticipated to drive the market growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global Huntington's disease treatment market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on type, drug type, age, distribution channel, and end user.

Type Insights:

Symptomatic Treatment

Disease-modifying Therapies

The report has also provided a detailed breakup and analysis of the Huntington's disease treatment market based on the type. This includes symptomatic treatment and disease-modifying therapies. According to the report, symptomatic treatment represented the largest segment.

Drug Type Insights:

Approved Drugs

Tetrabenazine

Deutetrabenazine

Off-label Drugs

A detailed breakup and analysis of the Huntington's disease treatment market based on the drug type has been provided in the report. This includes approved drugs (tetrabenazine and deutetrabenazine) and off-label drugs. According to the report, approved drugs accounted for the largest market share.

Age Insights:

Below 50 Years

Above 50 Years

A detailed breakup and analysis of the Huntington's disease treatment market based on the age has been provided in the report. This includes below 50 years and above 50 years. According to the report, below 50 years accounted for the largest market share.

Distribution Channel Insights:

Drug Stores and Retail Pharmacies

Hospital Pharmacies

Online Pharmacies

A detailed breakup and analysis of the Huntington's disease treatment market based on the distribution channel has been provided in the report. This includes drug store and retail, hospital, and online pharmacies. According to the report, drug store and retail pharmacies accounted for the largest market share.

End User Insights:

Hospitals

Homecare

Specialty Clinics

Others

A detailed breakup and analysis of the Huntington's disease treatment market based on the end users has been provided in the report. This includes hospitals, homecare, specialty clinics, and others.

Regional Insights:

North America

United States

Canada

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

The report has also provided a comprehensive analysis of all the major regional markets that include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and Middle East and Africa. According to the report, North America was the largest market for Huntington's disease treatment. Some of the factors driving the North America Huntington's disease treatment market includes significant technological advancements, the rapid development of healthcare infrastructure, and the rising number of individuals suffering from Huntington's disease.

Competitive Landscape:

The report has also provided a comprehensive analysis of the competitive landscape in the global Huntington's disease treatment market. Detailed profiles of all major companies have also been provided. Some of the companies covered include AOP Health, Apotex Inc., Dr. Reddy's Laboratories Ltd., H. Lundbeck A/S, Hikma Pharmaceuticals PLC, Lupin Limited, Prilenia Therapeutics, Sun Pharmaceutical Industries Limited, Teva Pharmaceutical Industries Ltd., Vaccinex Inc. etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in This Report

  • 1. What was the size of the global Huntington's disease treatment market in 2023?
  • 2. What is the expected growth rate of the global Huntington's disease treatment market during 2024-2032?
  • 3. What are the key factors driving the global Huntington's disease treatment market?
  • 4. What has been the impact of COVID-19 on the global Huntington's disease treatment market?
  • 5. What is the breakup of the global Huntington's disease treatment market based on the type?
  • 6. What is the breakup of the global Huntington's disease treatment market based on the drug type?
  • 7. What is the breakup of the global Huntington's disease treatment market based on the age?
  • 8. What is the breakup of the global Huntington's disease treatment market based on the distribution channel?
  • 9. What are the key regions in the global Huntington's disease treatment market?
  • 10. Who are the key players/companies in the global Huntington's disease treatment market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Huntington's Disease Treatment Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 Symptomatic Treatment
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Disease-modifying Therapies
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Drug Type

  • 7.1 Approved Drugs
    • 7.1.1 Market Trends
    • 7.1.2 Key Segments
      • 7.1.2.1 Tetrabenazine
      • 7.1.2.2 Deutetrabenazine
    • 7.1.3 Market Forecast
  • 7.2 Off-label Drugs
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by Age

  • 8.1 Below 50 Years
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Above 50 Years
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast

9 Market Breakup by Distribution Channel

  • 9.1 Drug Store and Retail Pharmacies
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Hospital Pharmacies
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Online Pharmacies
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast

10 Market Breakup by End User

  • 10.1 Hospitals
    • 10.1.1 Market Trends
    • 10.1.2 Market Forecast
  • 10.2 Homecare
    • 10.2.1 Market Trends
    • 10.2.2 Market Forecast
  • 10.3 Specialty Clinics
    • 10.3.1 Market Trends
    • 10.3.2 Market Forecast
  • 10.4 Others
    • 10.4.1 Market Trends
    • 10.4.2 Market Forecast

11 Market Breakup by Region

  • 11.1 North America
    • 11.1.1 United States
      • 11.1.1.1 Market Trends
      • 11.1.1.2 Market Forecast
    • 11.1.2 Canada
      • 11.1.2.1 Market Trends
      • 11.1.2.2 Market Forecast
  • 11.2 Asia-Pacific
    • 11.2.1 China
      • 11.2.1.1 Market Trends
      • 11.2.1.2 Market Forecast
    • 11.2.2 Japan
      • 11.2.2.1 Market Trends
      • 11.2.2.2 Market Forecast
    • 11.2.3 India
      • 11.2.3.1 Market Trends
      • 11.2.3.2 Market Forecast
    • 11.2.4 South Korea
      • 11.2.4.1 Market Trends
      • 11.2.4.2 Market Forecast
    • 11.2.5 Australia
      • 11.2.5.1 Market Trends
      • 11.2.5.2 Market Forecast
    • 11.2.6 Indonesia
      • 11.2.6.1 Market Trends
      • 11.2.6.2 Market Forecast
    • 11.2.7 Others
      • 11.2.7.1 Market Trends
      • 11.2.7.2 Market Forecast
  • 11.3 Europe
    • 11.3.1 Germany
      • 11.3.1.1 Market Trends
      • 11.3.1.2 Market Forecast
    • 11.3.2 France
      • 11.3.2.1 Market Trends
      • 11.3.2.2 Market Forecast
    • 11.3.3 United Kingdom
      • 11.3.3.1 Market Trends
      • 11.3.3.2 Market Forecast
    • 11.3.4 Italy
      • 11.3.4.1 Market Trends
      • 11.3.4.2 Market Forecast
    • 11.3.5 Spain
      • 11.3.5.1 Market Trends
      • 11.3.5.2 Market Forecast
    • 11.3.6 Russia
      • 11.3.6.1 Market Trends
      • 11.3.6.2 Market Forecast
    • 11.3.7 Others
      • 11.3.7.1 Market Trends
      • 11.3.7.2 Market Forecast
  • 11.4 Latin America
    • 11.4.1 Brazil
      • 11.4.1.1 Market Trends
      • 11.4.1.2 Market Forecast
    • 11.4.2 Mexico
      • 11.4.2.1 Market Trends
      • 11.4.2.2 Market Forecast
    • 11.4.3 Others
      • 11.4.3.1 Market Trends
      • 11.4.3.2 Market Forecast
  • 11.5 Middle East and Africa
    • 11.5.1 Market Trends
    • 11.5.2 Market Breakup by Country
    • 11.5.3 Market Forecast

12 Drivers, Restraints, and Opportunities

  • 12.1 Overview
  • 12.2 Drivers
  • 12.3 Restraints
  • 12.4 Opportunities

13 Value Chain Analysis

14 Porters Five Forces Analysis

  • 14.1 Overview
  • 14.2 Bargaining Power of Buyers
  • 14.3 Bargaining Power of Suppliers
  • 14.4 Degree of Competition
  • 14.5 Threat of New Entrants
  • 14.6 Threat of Substitutes

15 Price Analysis

16 Competitive Landscape

  • 16.1 Market Structure
  • 16.2 Key Players
  • 16.3 Profiles of Key Players
    • 16.3.1 AOP Health
      • 16.3.1.1 Company Overview
      • 16.3.1.2 Product Portfolio
    • 16.3.2 Apotex Inc.
      • 16.3.2.1 Company Overview
      • 16.3.2.2 Product Portfolio
      • 16.3.2.3 SWOT Analysis
    • 16.3.3 Dr. Reddy's Laboratories Ltd.
      • 16.3.3.1 Company Overview
      • 16.3.3.2 Product Portfolio
      • 16.3.3.3 Financials
      • 16.3.3.4 SWOT Analysis
    • 16.3.4 H. Lundbeck A/S
      • 16.3.4.1 Company Overview
      • 16.3.4.2 Product Portfolio
      • 16.3.4.3 Financials
      • 16.3.4.4 SWOT Analysis
    • 16.3.5 Hikma Pharmaceuticals PLC
      • 16.3.5.1 Company Overview
      • 16.3.5.2 Product Portfolio
      • 16.3.5.3 Financials
      • 16.3.5.4 SWOT Analysis
    • 16.3.6 Lupin Limited
      • 16.3.6.1 Company Overview
      • 16.3.6.2 Product Portfolio
      • 16.3.6.3 Financials
      • 16.3.6.4 SWOT Analysis
    • 16.3.7 Prilenia Therapeutics
      • 16.3.7.1 Company Overview
      • 16.3.7.2 Product Portfolio
    • 16.3.8 Sun Pharmaceutical Industries Limited
      • 16.3.8.1 Company Overview
      • 16.3.8.2 Product Portfolio
      • 16.3.8.3 Financials
      • 16.3.8.4 SWOT Analysis
    • 16.3.9 Teva Pharmaceutical Industries Ltd.
      • 16.3.9.1 Company Overview
      • 16.3.9.2 Product Portfolio
      • 16.3.9.3 Financials
      • 16.3.9.4 SWOT Analysis
    • 16.3.10 Vaccinex Inc.
      • 16.3.10.1 Company Overview
      • 16.3.10.2 Product Portfolio
      • 16.3.10.3 Financials

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

List of Figures

  • Figure 1: Global: Huntington's Disease Treatment Market: Major Drivers and Challenges
  • Figure 2: Global: Huntington's Disease Treatment Market: Sales Value (in Million US$), 2018-2023
  • Figure 3: Global: Huntington's Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 4: Global: Huntington's Disease Treatment Market: Breakup by Type (in %), 2023
  • Figure 5: Global: Huntington's Disease Treatment Market: Breakup by Drug Type (in %), 2023
  • Figure 6: Global: Huntington's Disease Treatment Market: Breakup by Age (in %), 2023
  • Figure 7: Global: Huntington's Disease Treatment Market: Breakup by Distribution Channel (in %), 2023
  • Figure 8: Global: Huntington's Disease Treatment Market: Breakup by End User (in %), 2023
  • Figure 9: Global: Huntington's Disease Treatment Market: Breakup by Region (in %), 2023
  • Figure 10: Global: Huntington's Disease Treatment (Symptomatic Treatment) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: Huntington's Disease Treatment (Symptomatic Treatment) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: Huntington's Disease Treatment (Disease-modifying Therapies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Huntington's Disease Treatment (Disease-modifying Therapies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Huntington's Disease Treatment (Approved Drugs) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Huntington's Disease Treatment (Approved Drugs) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Huntington's Disease Treatment (Off-label Drugs) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Huntington's Disease Treatment (Off-label Drugs) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Huntington's Disease Treatment (Below 50 Years) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Huntington's Disease Treatment (Below 50 Years) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Huntington's Disease Treatment (Above 50 Years) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Huntington's Disease Treatment (Above 50 Years) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Global: Huntington's Disease Treatment (Drug Store and Retail Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Global: Huntington's Disease Treatment (Drug Store and Retail Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: Global: Huntington's Disease Treatment (Hospital Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: Global: Huntington's Disease Treatment (Hospital Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: Global: Huntington's Disease Treatment (Online Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: Global: Huntington's Disease Treatment (Online Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: Global: Huntington's Disease Treatment (Hospitals) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: Global: Huntington's Disease Treatment (Hospitals) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: Global: Huntington's Disease Treatment (Homecare) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: Global: Huntington's Disease Treatment (Homecare) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: Global: Huntington's Disease Treatment (Specialty Clinics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: Global: Huntington's Disease Treatment (Specialty Clinics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: Global: Huntington's Disease Treatment (Other End Users) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: Global: Huntington's Disease Treatment (Other End Users) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: North America: Huntington's Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: North America: Huntington's Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: United States: Huntington's Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: United States: Huntington's Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: Canada: Huntington's Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: Canada: Huntington's Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: Asia-Pacific: Huntington's Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: Asia-Pacific: Huntington's Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: China: Huntington's Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: China: Huntington's Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: Japan: Huntington's Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: Japan: Huntington's Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: India: Huntington's Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: India: Huntington's Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: South Korea: Huntington's Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: South Korea: Huntington's Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: Australia: Huntington's Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: Australia: Huntington's Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: Indonesia: Huntington's Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: Indonesia: Huntington's Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: Others: Huntington's Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: Others: Huntington's Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: Europe: Huntington's Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: Europe: Huntington's Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: Germany: Huntington's Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: Germany: Huntington's Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 62: France: Huntington's Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 63: France: Huntington's Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: United Kingdom: Huntington's Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 65: United Kingdom: Huntington's Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: Italy: Huntington's Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 67: Italy: Huntington's Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: Spain: Huntington's Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 69: Spain: Huntington's Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 70: Russia: Huntington's Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 71: Russia: Huntington's Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 72: Others: Huntington's Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 73: Others: Huntington's Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 74: Latin America: Huntington's Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 75: Latin America: Huntington's Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 76: Brazil: Huntington's Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 77: Brazil: Huntington's Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 78: Mexico: Huntington's Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 79: Mexico: Huntington's Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 80: Others: Huntington's Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 81: Others: Huntington's Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 82: Middle East and Africa: Huntington's Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 83: Middle East and Africa: Huntington's Disease Treatment Market: Breakup by Country (in %), 2023
  • Figure 84: Middle East and Africa: Huntington's Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 85: Global: Huntington's Disease Treatment Industry: Drivers, Restraints, and Opportunities
  • Figure 86: Global: Huntington's Disease Treatment Industry: Value Chain Analysis
  • Figure 87: Global: Huntington's Disease Treatment Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Huntington's Disease Treatment Market: Key Industry Highlights, 2023 & 2032
  • Table 2: Global: Huntington's Disease Treatment Market Forecast: Breakup by Type (in Million US$), 2024-2032
  • Table 3: Global: Huntington's Disease Treatment Market Forecast: Breakup by Drug Type (in Million US$), 2024-2032
  • Table 4: Global: Huntington's Disease Treatment Market Forecast: Breakup by Age (in Million US$), 2024-2032
  • Table 5: Global: Huntington's Disease Treatment Market Forecast: Breakup by Distribution Channel (in Million US$), 2024-2032
  • Table 6: Global: Huntington's Disease Treatment Market Forecast: Breakup by End User (in Million US$), 2024-2032
  • Table 7: Global: Huntington's Disease Treatment Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 8: Global: Huntington's Disease Treatment Market: Competitive Structure
  • Table 9: Global: Huntington's Disease Treatment Market: Key Players